Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Scientific Reports|August 28, 2025
Impacts of immune checkpoint inhibitors use on the HIV reservoir are linked to provirus sequences but not integration sitesVincent Guiraud, Antoine Fauchois, Cathia Soulie, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2014
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 studyChristine Katlama, Lambert Assoumou, Marc-Antoine Valantin, et al.
British Journal of Clinical Pharmacology|October 3, 2020
Pharmacological data of a successful 4-days-a-week regimen in HIV antiretroviral therapy (ANRS 162-4D trial)Emuri Abe, Lambert Assoumou, Pierre de Truchis, et al.
Open Forum Infectious Diseases|July 11, 2026
Predictors of Cerebral Small-Vessel Disease in Middle-Aged, Virologically Controlled People Living With HIVAntoine Moulignier, Cédric Lamirel, Arbnor Zenuni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2022
Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV CentreRomain Palich, Rachid Agher, Dimoke J Wetshikoy, et al.
Open Forum Infectious Diseases|July 6, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero CohortsConstance Delaugerre, Lambert Assoumou, Sarah Maylin, et al.
AIDS and Behavior|April 27, 2026
Factors Associated with Not Seeking Post-exposure Prophylaxis for HIV Among PrEP-Naive Men Who Have Sex with Men: An Analysis from the French ANRS-PREVENIR StudyJuan Camilo Jones, Marie Costa, Luis Sagaon-Teyssier, et al.
AIDS (London, England)|December 3, 2009
Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapyAmélie Guihot, Roland Tubiana, Guillaume Breton, et al.
AIDS (London, England)|December 20, 2015
Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trialChristine Katlama, Sidonie Lambert-Niclot, Lambert Assoumou, et al.
AIDS Research and Human Retroviruses|July 14, 2016
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap TrialValérie Pourcher, Aude Desnoyer, Lambert Assoumou, et al.
Pageof 13